|
Patient N (%)
|
181 (52.6%)
|
163 (47.4%)
|
344 (100.0%)
|
|
Years of age‡
|
30.4 ± 9.3
|
32.6 ± 9.4
|
31.5 ± 9.4
|
|
Male sex
|
82 (45.3%)
|
69 (42.6%)
|
151 (44.0%)
|
|
Current smoker
|
6 (3.3%)
|
10 (6.1%)
|
16 (4.7%)
|
|
Years since asthma diagnosed
|
8.5 ± 7.6
|
8.0 ± 7.7
|
8.3 ± 7.7
|
|
Years since allergic rhinitis diagnosed‡
|
10.7 ± 8.2
|
8.4 ± 7.7
|
9.6 ± 8.1
|
|
Allergic rhinitis severity
| | | |
|
Mild intermittent
|
60 (33.2%)
|
64 (39.3%)
|
124 (36.1%)
|
|
Mild persistent
|
87 (48.1%)
|
74 (45.4%)
|
161 (46.8%)
|
|
Moderate-severe intermittent
|
26 (14.4%)
|
15 (9.2%)
|
41 (11.9%)
|
|
Moderate-severe persistent
|
8 (4.4%)
|
10 (6.1%)
|
18 (5.2%)
|
|
Months on therapy in prior 12 months
| | | |
|
ICS‡
|
10.5 ± 3.4
|
11.2 ± 2.4
|
10.8 ± 3.0
|
|
ICS/LABA‡
|
1.1 ± 3.2
|
8.0 ± 5.2
|
4.4 ± 5.5
|
|
Asthma- and allergic rhinitis-related medical resource use in prior 12 months
| | | |
|
Short-acting beta-agonist
|
155 (85.6%)
|
130 (79.8%)
|
285 (82.9%)
|
|
Oral corticosteroids
|
21 (11.6%)
|
24 (14.7%)
|
45 (13.1%)
|
|
Antibiotics
|
38 (21.0%)
|
44 (27.0%)
|
82 (23.8%)
|
|
Antihistamines
|
129 (71.3%)
|
104 (63.8%)
|
233 (67.7%)
|
|
Allergist visit‡
|
85 (47.0%)
|
54 (33.1%)
|
139 (40.4%)
|
|
Pulmonologist visit
|
1 (0.6%)
|
1 (0.6%)
|
2 (0.6%)
|
|
Emergency Room visit
|
34 (18.8%)
|
23 (14.1%)
|
57 (16.6%)
|
|
Hospitalization
|
7 (3.9%)
|
3 (1.8%)
|
10 (2.9%)
|
|
Asthma attack†
|
49 (27.1%)
|
44 (27.0%)
|
93 (27.0%)
|
|
Months on therapy in 12-month follow-up‡
|
10.5 ± 2.9
|
11.4 ± 1.9
|
10.9 ± 2.5
|
